Financial results: Elixinol; Emyria; Epsilon; Avecho; Creso Pharma; AusCann; MGC Pharma; Botanix; Zelira by Martin Lane and Steve Jones March 1, 2023April 30, 2024 Elixinol Wellness reported a 2022 year-end loss of A$10.5m, a 38% improvement on the previous year, […]
